National Cancer Institute - U.S. National Institutes of Health - www.cancer.govSkip navigationNational Cancer Institute - U.S. National Institutes of Health - www.cancer.govClinical Trials at NIH - Be part of the cure
National Cancer Institute - U.S. National Institutes of Health - www.cancer.gov
Clinical Trials at NIH Home

Investigator Profiles

Brigitte Widemann, M.D.

Brigitte Charlotte Widemann, M.D.

Pediatric Oncology Branch
Pharmacology and Experimental
Therapeutics Section
Senior Investigator

National Cancer Institute
10 Center Drive
Building 10, Room 13C103
Bethesda, MD 20982

Phone: 301-496-7387
Fax: 301-480-8871
widemanb@mail.nih.gov

Dr. Widemann is a senior investigator at the NCI Pediatric Oncology Branch (POB). After obtaining her M.D., from the University of Cologne, Germany, in 1986, Dr. Widemann received board certification in pediatrics in 1992 and was a hematology/oncology fellow at NCI POB from 1992 to 1995. She subsequently joined the Pharmacology and Experimental Therapeutics Section of POB and received tenure at NCI in 2009. Dr. Widemann’s primary research interests are the development of targeted therapies for refractory childhood cancers and neurofibromatosis type 1-related tumors.

Dr. Widemann's Clinical Trial(s):

NCI’s Center for Cancer Research (CCR) is currently conducting the following trial(s) for patients with pediatric cancers or neurofibroma/neurofibromatosis. Click on the trial(s) below for additional details, including a summary of key eligibility criteria, study outline, and information on how to contact the study team directly.

Back to Top
Health and Human Services National Institutes of Health National Cancer Institute USA.gov